BAG Films & Media Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 22, 2025, 8:14 am

Competitors of BAG Films & Media Ltd

All Competitor Stocks of BAG Films & Media Ltd

Quarterly Result

Last Updated: August 19, 2025, 10:45 pm

Below is a detailed analysis of the quarterly data for BAG Films & Media Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 31.47 Cr.. The value appears to be declining and may need further review. It has decreased from 41.89 Cr. (Mar 2025) to 31.47 Cr., marking a decrease of 10.42 Cr..
• For Expenses, as of Jun 2025, the value is 26.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 31.78 Cr. (Mar 2025) to 26.11 Cr., marking a decrease of 5.67 Cr..
• For Operating Profit, as of Jun 2025, the value is 5.36 Cr.. The value appears to be declining and may need further review. It has decreased from 10.11 Cr. (Mar 2025) to 5.36 Cr., marking a decrease of 4.75 Cr..
• For OPM %, as of Jun 2025, the value is 17.03%. The value appears to be declining and may need further review. It has decreased from 24.13% (Mar 2025) to 17.03%, marking a decrease of 7.10%.
• For Other Income, as of Jun 2025, the value is 0.09 Cr.. The value appears to be declining and may need further review. It has decreased from 1.47 Cr. (Mar 2025) to 0.09 Cr., marking a decrease of 1.38 Cr..
• For Interest, as of Jun 2025, the value is 2.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.31 Cr. (Mar 2025) to 2.11 Cr., marking a decrease of 0.20 Cr..
• For Depreciation, as of Jun 2025, the value is 0.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.91 Cr. (Mar 2025) to 0.55 Cr., marking a decrease of 0.36 Cr..
• For Profit before tax, as of Jun 2025, the value is 2.79 Cr.. The value appears to be declining and may need further review. It has decreased from 8.36 Cr. (Mar 2025) to 2.79 Cr., marking a decrease of 5.57 Cr..
• For Tax %, as of Jun 2025, the value is 19.35%. The value appears to be improving (decreasing) as expected. It has decreased from 22.25% (Mar 2025) to 19.35%, marking a decrease of 2.90%.
• For Net Profit, as of Jun 2025, the value is 2.25 Cr.. The value appears to be declining and may need further review. It has decreased from 6.49 Cr. (Mar 2025) to 2.25 Cr., marking a decrease of 4.24 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.08. The value appears to be declining and may need further review. It has decreased from 0.18 (Mar 2025) to 0.08, marking a decrease of 0.10.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 3:50 am

Growth

Last Updated: September 5, 2025, 2:35 pm

Balance Sheet

Last Updated: September 10, 2025, 3:08 pm

Below is a detailed analysis of the balance sheet data for BAG Films & Media Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 40.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 40.00 Cr..
• For Reserves, as of Mar 2025, the value is 118.00 Cr.. The value appears strong and on an upward trend. It has increased from 111.00 Cr. (Mar 2024) to 118.00 Cr., marking an increase of 7.00 Cr..
• For Borrowings, as of Mar 2025, the value is 120.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 108.00 Cr. (Mar 2024) to 120.00 Cr., marking an increase of 12.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 120.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 120.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 398.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 379.00 Cr. (Mar 2024) to 398.00 Cr., marking an increase of 19.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Mar 2024) to 22.00 Cr., marking a decrease of 6.00 Cr..
• For CWIP, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
• For Investments, as of Mar 2025, the value is 123.00 Cr.. The value appears to be declining and may need further review. It has decreased from 125.00 Cr. (Mar 2024) to 123.00 Cr., marking a decrease of 2.00 Cr..
• For Other Assets, as of Mar 2025, the value is 252.00 Cr.. The value appears strong and on an upward trend. It has increased from 225.00 Cr. (Mar 2024) to 252.00 Cr., marking an increase of 27.00 Cr..
• For Total Assets, as of Mar 2025, the value is 398.00 Cr.. The value appears strong and on an upward trend. It has increased from 379.00 Cr. (Mar 2024) to 398.00 Cr., marking an increase of 19.00 Cr..

However, the Borrowings (120.00 Cr.) are higher than the Reserves (118.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for BAG Films & Media Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 5. It has increased from 0.33 (Mar 24) to 0.50, marking an increase of 0.17.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 5. It has increased from 0.28 (Mar 24) to 0.41, marking an increase of 0.13.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 3. It has increased from 0.58 (Mar 24) to 0.71, marking an increase of 0.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 7.95. It has decreased from 10.52 (Mar 24) to 7.95, marking a decrease of 2.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 7.95. It has decreased from 10.52 (Mar 24) to 7.95, marking a decrease of 2.57.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 6.87. It has increased from 6.67 (Mar 24) to 6.87, marking an increase of 0.20.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 2. It has increased from 1.18 (Mar 24) to 1.25, marking an increase of 0.07.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.04. This value is within the healthy range. It has increased from 0.93 (Mar 24) to 1.04, marking an increase of 0.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.61. This value is within the healthy range. It has increased from 0.42 (Mar 24) to 0.61, marking an increase of 0.19.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 2. It has increased from 0.34 (Mar 24) to 0.50, marking an increase of 0.16.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.31. This value is below the healthy minimum of 2. It has increased from 0.20 (Mar 24) to 0.31, marking an increase of 0.11.
• For PBDIT Margin (%), as of Mar 25, the value is 18.18. This value is within the healthy range. It has increased from 17.64 (Mar 24) to 18.18, marking an increase of 0.54.
• For PBIT Margin (%), as of Mar 25, the value is 15.16. This value is within the healthy range. It has increased from 14.01 (Mar 24) to 15.16, marking an increase of 1.15.
• For PBT Margin (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has increased from 6.38 (Mar 24) to 9.00, marking an increase of 2.62.
• For Net Profit Margin (%), as of Mar 25, the value is 7.34. This value is within the healthy range. It has increased from 5.13 (Mar 24) to 7.34, marking an increase of 2.21.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.56. This value is below the healthy minimum of 8. It has increased from 3.02 (Mar 24) to 4.56, marking an increase of 1.54.
• For Return on Networth / Equity (%), as of Mar 25, the value is 3.94. This value is below the healthy minimum of 15. It has increased from 2.63 (Mar 24) to 3.94, marking an increase of 1.31.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.89. This value is below the healthy minimum of 10. It has increased from 7.43 (Mar 24) to 7.89, marking an increase of 0.46.
• For Return On Assets (%), as of Mar 25, the value is 1.56. This value is below the healthy minimum of 5. It has increased from 1.05 (Mar 24) to 1.56, marking an increase of 0.51.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. There is no change compared to the previous period (Mar 24) which recorded 0.34.
• For Current Ratio (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has increased from 1.70 (Mar 24) to 1.83, marking an increase of 0.13.
• For Quick Ratio (X), as of Mar 25, the value is 1.35. This value is within the healthy range. It has increased from 1.32 (Mar 24) to 1.35, marking an increase of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.36. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 2.36, marking an increase of 2.36.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.95. This value is below the healthy minimum of 3. It has increased from 2.31 (Mar 24) to 2.95, marking an increase of 0.64.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 2.19. This value is below the healthy minimum of 3. It has increased from 1.67 (Mar 24) to 2.19, marking an increase of 0.52.
• For Enterprise Value (Cr.), as of Mar 25, the value is 156.04. It has decreased from 210.28 (Mar 24) to 156.04, marking a decrease of 54.24.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.15. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 1.15, marking a decrease of 0.44.
• For EV / EBITDA (X), as of Mar 25, the value is 6.31. This value is within the healthy range. It has decreased from 9.04 (Mar 24) to 6.31, marking a decrease of 2.73.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 1.24 (Mar 24) to 0.78, marking a decrease of 0.46.
• For Price / BV (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 1.08 (Mar 24) to 0.67, marking a decrease of 0.41.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.78. This value is below the healthy minimum of 1. It has decreased from 1.24 (Mar 24) to 0.78, marking a decrease of 0.46.
• For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 24) to 0.05, marking an increase of 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness